Sinus Disease in Young Children With Cystic Fibrosis | MicrobiomeTrials← Back to trialsNCT06191640
Sinus Disease in Young Children With Cystic Fibrosis
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-04-12Est. Completion: 2029-06-30
Enrollment target: 80 participants Locations- Children's Hospital Colorado, Aurora, Colorado, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- University of Vermont, Colchester, Vermont, United States
- University of Virginia, Charlottesville, Virginia, United States
Other microbiome trials you might be interested in
Cystic Fibrosis
This study will evaluate the long-term safety, efficacy and pharmacodynamics of ELX/TEZ/IVA in participants with cystic …
Innsbruck, AustriaEst. completion Apr 6, 2027
Cystic FibrosisPulmonary FibrosisTuberous SclerosisAsthmaPulmonary Sarcoidosis
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved …
Bethesda, United States
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivaca…
Birmingham, United StatesEst. completion Oct 30, 2026